Skip to content

NTRB

NutriBand Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.13
+6.27%
Ask drillr

Year over year

Reported trailing growth

Revenue
-37.3%
EBITDA
+31.8%
EBIT
-3.5%
EPS
+80.1%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
-72.2%
EBITDA
EPS

Three-year CAGR

Revenue
-0.7%
EBITDA
+21.3%
EBIT
-24.3%
Net income
+21.5%
EPS
Free cash flow
-8.8%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026